Pharmacogenetic testing, contraceptives, and more!
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Q&A: Pharmacists Play Essential Role in Insulin Therapy Success
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.
Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic Disease
Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.
CGRP Medication Did Not Prevent Cluster Headache Attacks
Investigators find that erenumab, a calcitonin gene-related peptide receptor (CGRP) monoclonal antibody, is not a preventative treatment for chronic cluster headache.
The Overarching Implications of PBM Reform on the State Level
With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.
Q&A: Congressman Highlights PBM Reform Bill | McKesson ideaShare
Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.
Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.